PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-1.33%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-11.24%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-53.58%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-55.16%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-50.42%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-50.00%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-49.02%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-0.70%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.35%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
31.32%
Dividend growth above 1.5x ADI's 0.39%. David Dodd would verify if the firm's cash flow is robust enough for these payouts.
-14.67%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-13.44%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
169.55%
10Y revenue/share CAGR above 1.5x ADI's 106.30%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
27.62%
5Y revenue/share CAGR similar to ADI's 26.41%. Walter Schloss might see both companies benefiting from the same mid-term trends.
54.82%
3Y revenue/share CAGR above 1.5x ADI's 5.99%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
75.33%
10Y OCF/share CAGR at 75-90% of ADI's 91.82%. Bill Ackman would demand strategic changes to close the gap in long-term cash generation.
48.49%
5Y OCF/share CAGR at 75-90% of ADI's 57.00%. Bill Ackman would push for operational improvements to match competitor’s mid-term gains.
-2.06%
Negative 3Y OCF/share CAGR while ADI stands at 58.20%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
461.83%
Net income/share CAGR at 50-75% of ADI's 824.79%. Martin Whitman might question if the firm’s product or cost base lags behind.
-42.35%
Negative 5Y net income/share CAGR while ADI is 50.80%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
214.05%
3Y net income/share CAGR above 1.5x ADI's 24.74%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
29.85%
Below 50% of ADI's 62.80%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
24.58%
5Y equity/share CAGR is in line with ADI's 25.64%. Walter Schloss would see parallel mid-term profitability and retention policies.
32.42%
3Y equity/share CAGR at 50-75% of ADI's 53.34%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
655.09%
Dividend/share CAGR of 655.09% while ADI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
330.01%
5Y dividend/share CAGR above 1.5x ADI's 52.95%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
54.35%
3Y dividend/share CAGR above 1.5x ADI's 25.92%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
-13.40%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-9.01%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-1.96%
Negative asset growth while ADI invests at 0.50%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
0.03%
Under 50% of ADI's 2.77%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-3.60%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
20.00%
We increase R&D while ADI cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
14.43%
We expand SG&A while ADI cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.